Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPPANDEY, Ramendra P.NASCIMENTO, Marilda SavoiaFRANCO, Caio HaddadBORTOLUCI, KarinaSILVA, Marcelo NunesZINGALES, BiancaGIBALDI, DanielBARRIOS, Leda CastanoLANNES-VIEIRA, JoseliCARISTE, Leonardo MoroVASCONCELOS, Jose RonnieMORAES, Carolina BorsoiFREITAS-JUNIOR, Lucio H.KALIL, JorgeALCANTARA, LauraCUNHA-NETO, Edecio2022-12-212022-12-212022ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, v.66, n.11, 20220066-4804https://observatorio.fm.usp.br/handle/OPI/50378Drug combinations and drug repurposing have emerged as promising strategies to develop novel treatments for infectious diseases, including Chagas disease. In this study, we aimed to investigate whether the repurposed drugs chloroquine (CQ) and colchicine (COL), known to inhibit Trypanosoma cruzi infection in host cells, could boost the anti-T. cruzi effect of the trypanocidal drug benznidazole (BZN), increasing its therapeutic efficacy while reducing the dose needed to eradicate the parasite. The combination of BZN and COL exhibited cytotoxicity to infected cells and low antiparasitic activity. Conversely, a combination of BZN and CQ significantly reduced T. cruzi infection in vitro, with no apparent cytotoxicity. This effect seemed to be consistent across different cell lines and against both the partially BZN-resistant Y and the highly BZN-resistant Colombiana strains. In vivo experiments in an acute murine model showed that the BZN+CQ combination was eight times more effective in reducing T. cruzi infection in the acute phase than BZN monotherapy. In summary, our results demonstrate that the concomitant administration of CQ and BZN potentiates the trypanocidal activity of BZN, leading to a reduction in the dose needed to achieve an effective response. In a translational context, it could represent a higher efficacy of treatment while also mitigating the adverse effects of high doses of BZN. Our study also reinforces the relevance of drug combination and repurposing approaches in the field of Chagas disease drug discovery.engrestrictedAccessChagas disease drug discoverydrug combinationdrug repurposingchloroquinebenznidazolerandomized-trialcell invasionposaconazolecombinationphagosomeregimensstrainsburdenmicearticleCopyright AMER SOC MICROBIOLOGY10.1128/aac.00284-22MicrobiologyPharmacology & Pharmacy1098-6596